| The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis ZM Younossi, P Golabi, L de Avila, JM Paik, M Srishord, N Fukui, Y Qiu, ... Journal of hepatology 71 (4), 793-801, 2019 | 2071 | 2019 |
| The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review ZM Younossi, P Golabi, JM Paik, A Henry, C Van Dongen, L Henry Hepatology 77 (4), 1335-1347, 2023 | 1412 | 2023 |
| Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD JM Paik, P Golabi, Y Younossi, A Mishra, ZM Younossi Hepatology 72 (5), 1605-1616, 2020 | 709 | 2020 |
| Epidemiology of chronic liver diseases in the USA in the past three decades ZM Younossi, M Stepanova, Y Younossi, P Golabi, A Mishra, N Rafiq, ... Gut 69 (3), 564-568, 2020 | 503 | 2020 |
| Disease burden of hepatocellular carcinoma: a global perspective M Sayiner, P Golabi, ZM Younossi Digestive diseases and sciences 64, 910-917, 2019 | 355 | 2019 |
| Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities P Golabi, S Fazel, M Otgonsuren, M Sayiner, CT Locklear, ZM Younossi Medicine 96 (9), e5904, 2017 | 291 | 2017 |
| Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review P Golabi, CT Locklear, P Austin, S Afdhal, M Byrns, L Gerber, ... World journal of gastroenterology 22 (27), 6318, 2016 | 278 | 2016 |
| Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD) P Golabi, M Otgonsuren, L de Avila, M Sayiner, N Rafiq, ZM Younossi Medicine 97 (13), e0214, 2018 | 226 | 2018 |
| Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: Data from Global Burden of Disease 2009-2019 P Golabi, JM Paik, S AlQahtani, Y Younossi, G Tuncer, ZM Younossi Journal of hepatology 75 (4), 795-809, 2021 | 172 | 2021 |
| Non-alcoholic fatty liver disease (NAFLD) is associated with impairment of health related quality of life (HRQOL) P Golabi, M Otgonsuren, R Cable, S Felix, A Koenig, M Sayiner, ... Health and quality of life outcomes 14, 1-7, 2016 | 170 | 2016 |
| Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease? ZM Younossi, JM Paik, R Al Shabeeb, P Golabi, I Younossi, L Henry Hepatology 76 (5), 1423-1437, 2022 | 139 | 2022 |
| Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States P Golabi, J Paik, R Reddy, E Bugianesi, G Trimble, ZM Younossi BMC gastroenterology 19, 1-8, 2019 | 119 | 2019 |
| Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality P Golabi, J Paik, N Fukui, CT Locklear, L de Avilla, ZM Younossi Clinical diabetes 37 (1), 65-72, 2019 | 114 | 2019 |
| Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease P Golabi, L Gerber, JM Paik, R Deshpande, L de Avila, ZM Younossi JHEP Reports 2 (6), 100171, 2020 | 107 | 2020 |
| Assessment of health utilities and quality of life in patients with non-alcoholic fatty liver disease M Sayiner, M Stepanova, H Pham, B Noor, M Walters, ZM Younossi BMJ open gastroenterology 3 (1), e000106, 2016 | 95 | 2016 |
| Variables associated with inpatient and outpatient resource utilization among Medicare beneficiaries with nonalcoholic fatty liver disease with or without cirrhosis M Sayiner, M Otgonsuren, R Cable, I Younossi, M Afendy, P Golabi, ... Journal of clinical gastroenterology 51 (3), 254-260, 2017 | 86 | 2017 |
| Pediatric non-alcoholic fatty liver disease H Bush, P Golabi, ZM Younossi Children 4 (6), 48, 2017 | 85 | 2017 |
| Mortality of NAFLD according to the body composition and presence of metabolic abnormalities P Golabi, JM Paik, T Arshad, Y Younossi, A Mishra, ZM Younossi Hepatology communications 4 (8), 1136-1148, 2020 | 82 | 2020 |
| The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007‐2017 JM Paik, P Golabi, Y Younossi, M Srishord, A Mishra, ZM Younossi Hepatology communications 4 (12), 1769-1780, 2020 | 81 | 2020 |
| Liver transplantation (LT) for cryptogenic cirrhosis (CC) and nonalcoholic steatohepatitis (NASH) cirrhosis: data from the scientific registry of transplant recipients (SRTR … P Golabi, H Bush, M Stepanova, CT Locklear, IM Jacobson, A Mishra, ... Medicine 97 (31), e11518, 2018 | 79 | 2018 |
